Efficacy and safety of different dosing regimens of rituximab in primary membranous nephropathy: protocol for a systematic review and meta-analysis

INTRODUCTION: Primary membranous nephropathy (PMN) is a major cause of nephrotic syndrome in adults. Rituximab has been recommended in the treatment of PMN by the updated Kidney Disease Improved Outcome guideline. However, the optimal dosing regimen of rituximab for the initial treatment of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yongxing, Yang, Qing, Fu, Chen, Han, Enhong, Gao, Yuehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853246/
https://www.ncbi.nlm.nih.gov/pubmed/36657752
http://dx.doi.org/10.1136/bmjopen-2022-064220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853246/
https://www.ncbi.nlm.nih.gov/pubmed/36657752
http://dx.doi.org/10.1136/bmjopen-2022-064220

Ejemplares similares